Effect of artesunate on maximal electroshock and pentylenetetrazole-induced seizures in albino mice

K. Sanjana, M. Shyamjith, B. Deepa, Sathynarayana Rao, Preethi Pai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Artemisinin-based combination therapies are highly efficacious, and they are now listed as first-line therapies for uncomplicated malaria in most countries where malaria is endemic. Neurotoxicity of artemisinins is a growing concern. However, no studies have reported its antiepileptic or epileptogenesis potential, hence the present study was undertaken to explore the activity of artesunate in experimentally induced seizures in rodent models. Artesunate at doses 36.4 and 72.8 mg/kg respectively significantly reduced the duration of the hind limb extensions (3.033±1.493 and 2.033±1.383, respectively) when compared to the control (P<0.0001) in the maximal electroshock-induced seizure model. However, no significant decrease was noted in the duration of clonic convulsions in a pentylenetetrazole-induced seizure model indicating lack of activity in petit mal epilepsy. The results of the present study indicate that artesunate at both the doses employed showed a significant anticonvulsant activity in the maximum electroshock-induced seizure model suggesting its potential utility in the management of generalized tonic-clonic seizures and partial seizures. Further studies regarding its mechanism of action are warranted.

Original languageEnglish
Pages (from-to)63-66
Number of pages4
JournalInternational Journal of Green Pharmacy
Volume6
Issue number1
DOIs
Publication statusPublished - 01-01-2012

Fingerprint

Electroshock
Pentylenetetrazole
Seizures
Anticonvulsants
Malaria
Artemisinins
Absence Epilepsy
artesunate
Rodentia
Extremities
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Sanjana, K. ; Shyamjith, M. ; Deepa, B. ; Rao, Sathynarayana ; Pai, Preethi. / Effect of artesunate on maximal electroshock and pentylenetetrazole-induced seizures in albino mice. In: International Journal of Green Pharmacy. 2012 ; Vol. 6, No. 1. pp. 63-66.
@article{909c20f8727d45f7afed26d4efb30c66,
title = "Effect of artesunate on maximal electroshock and pentylenetetrazole-induced seizures in albino mice",
abstract = "Artemisinin-based combination therapies are highly efficacious, and they are now listed as first-line therapies for uncomplicated malaria in most countries where malaria is endemic. Neurotoxicity of artemisinins is a growing concern. However, no studies have reported its antiepileptic or epileptogenesis potential, hence the present study was undertaken to explore the activity of artesunate in experimentally induced seizures in rodent models. Artesunate at doses 36.4 and 72.8 mg/kg respectively significantly reduced the duration of the hind limb extensions (3.033±1.493 and 2.033±1.383, respectively) when compared to the control (P<0.0001) in the maximal electroshock-induced seizure model. However, no significant decrease was noted in the duration of clonic convulsions in a pentylenetetrazole-induced seizure model indicating lack of activity in petit mal epilepsy. The results of the present study indicate that artesunate at both the doses employed showed a significant anticonvulsant activity in the maximum electroshock-induced seizure model suggesting its potential utility in the management of generalized tonic-clonic seizures and partial seizures. Further studies regarding its mechanism of action are warranted.",
author = "K. Sanjana and M. Shyamjith and B. Deepa and Sathynarayana Rao and Preethi Pai",
year = "2012",
month = "1",
day = "1",
doi = "10.4103/0973-8258.97132",
language = "English",
volume = "6",
pages = "63--66",
journal = "International Journal of Green Pharmacy",
issn = "0973-8258",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

Effect of artesunate on maximal electroshock and pentylenetetrazole-induced seizures in albino mice. / Sanjana, K.; Shyamjith, M.; Deepa, B.; Rao, Sathynarayana; Pai, Preethi.

In: International Journal of Green Pharmacy, Vol. 6, No. 1, 01.01.2012, p. 63-66.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of artesunate on maximal electroshock and pentylenetetrazole-induced seizures in albino mice

AU - Sanjana, K.

AU - Shyamjith, M.

AU - Deepa, B.

AU - Rao, Sathynarayana

AU - Pai, Preethi

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Artemisinin-based combination therapies are highly efficacious, and they are now listed as first-line therapies for uncomplicated malaria in most countries where malaria is endemic. Neurotoxicity of artemisinins is a growing concern. However, no studies have reported its antiepileptic or epileptogenesis potential, hence the present study was undertaken to explore the activity of artesunate in experimentally induced seizures in rodent models. Artesunate at doses 36.4 and 72.8 mg/kg respectively significantly reduced the duration of the hind limb extensions (3.033±1.493 and 2.033±1.383, respectively) when compared to the control (P<0.0001) in the maximal electroshock-induced seizure model. However, no significant decrease was noted in the duration of clonic convulsions in a pentylenetetrazole-induced seizure model indicating lack of activity in petit mal epilepsy. The results of the present study indicate that artesunate at both the doses employed showed a significant anticonvulsant activity in the maximum electroshock-induced seizure model suggesting its potential utility in the management of generalized tonic-clonic seizures and partial seizures. Further studies regarding its mechanism of action are warranted.

AB - Artemisinin-based combination therapies are highly efficacious, and they are now listed as first-line therapies for uncomplicated malaria in most countries where malaria is endemic. Neurotoxicity of artemisinins is a growing concern. However, no studies have reported its antiepileptic or epileptogenesis potential, hence the present study was undertaken to explore the activity of artesunate in experimentally induced seizures in rodent models. Artesunate at doses 36.4 and 72.8 mg/kg respectively significantly reduced the duration of the hind limb extensions (3.033±1.493 and 2.033±1.383, respectively) when compared to the control (P<0.0001) in the maximal electroshock-induced seizure model. However, no significant decrease was noted in the duration of clonic convulsions in a pentylenetetrazole-induced seizure model indicating lack of activity in petit mal epilepsy. The results of the present study indicate that artesunate at both the doses employed showed a significant anticonvulsant activity in the maximum electroshock-induced seizure model suggesting its potential utility in the management of generalized tonic-clonic seizures and partial seizures. Further studies regarding its mechanism of action are warranted.

UR - http://www.scopus.com/inward/record.url?scp=84862742546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862742546&partnerID=8YFLogxK

U2 - 10.4103/0973-8258.97132

DO - 10.4103/0973-8258.97132

M3 - Article

AN - SCOPUS:84862742546

VL - 6

SP - 63

EP - 66

JO - International Journal of Green Pharmacy

JF - International Journal of Green Pharmacy

SN - 0973-8258

IS - 1

ER -